FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Novavax Amends Covid Vaccine EUA

Novavax files an amendment to its Emergency Use Authorization for an updated JN.1 Covid-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.

latest-news-card-1
Human Drugs

Guide on Diabetic Foot Infection Drugs

FDA posts a final guidance entitled Diabetic Foot Infections (DFI): Developing Drugs for Treatment.

latest-news-card-1
Human Drugs

Amgens Blincyto Gets Expanded Leukemia Use

FDA approves an expanded use for Amgens Blincyto (blinatumomab) for treating adult and pediatric patients one month or older with lymphoblastic leukem...

latest-news-card-1
Human Drugs

3 Bayesian Examples Added to Demonstration Project

FDA adds three Bayesian statistical analysis examples to the CDER Center for Clinical Trial Innovation Web page.

latest-news-card-1
Human Drugs

Supreme Court Rejects Mifepristone Lawsuit

The U.S. Supreme Court 6/13 unanimously rejects a lawsuit seeking to sharply restrict distribution of the chemical abortion pill mifepristone (Dancos ...

Biologics

FDA Revises Covid Vaccine Composition Recommendation

FDA updates its advice on this falls Covid-19 vaccine composition based on a recent review of circulating Covid cases in the U.S.

latest-news-card-1
Biologics

Pfizer Duchene Gene Therapy Fails Phase 3 Study

Pfizer says that its Phase 3 CIFFREO placebo-controlled study evaluating an investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec...

latest-news-card-1
Federal Register

Shaver Permanently Debarred by FDA

Federal Register notice: FDA issues an order permanently debarring Jonathan R. Shaver from providing services in any capacity to a person that has an ...

latest-news-card-1
Federal Register

FDA Debars Smith for 5 Years

Federal Register notice: FDA issues an order debarring Richard B. Smith III for five years from importing or offering for import any drug into the U.S...

latest-news-card-1
Human Drugs

Emerging Drug Safety Technology Meeting Program

CDER Office of Surveillance and Epidemiology deputy director Robert Ball describes the Emerging Drug Safety Technology Meeting program that offers acc...